» Articles » PMID: 20198437

Inefficient Clearance of Dying Cells in Patients with SLE: Anti-dsDNA Autoantibodies, MFG-E8, HMGB-1 and Other Players

Overview
Journal Apoptosis
Publisher Springer
Date 2010 Mar 4
PMID 20198437
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Systemic lupus erythematosus (SLE) is a complex disease resulting from inflammatory responses of the immune system against several autoantigens. Inflammation is conditioned by the continuous presence of autoantibodies and leaked autoantigens, e.g. from not properly cleared dying and dead cells. Various soluble molecules and biophysical properties of the surface of apoptotic cells play significant roles in the appropriate recognition and further processing of dying and dead cells. We exemplarily discuss how Milk fat globule epidermal growth factor 8 (MFG-E8), biophysical membrane alterations, High mobility group box 1 (HMGB1), C-reactive protein (CRP), and anti-nuclear autoantibodies may contribute to the etiopathogenesis of the disease. Up to date knowledge about these key elements may provide new insights that lead to the development of new treatment strategies of the disease.

Citing Articles

The Expression of Toll-like Receptors (TLR7 and TLR9) in Class III and Class IV of Recently Diagnosed Lupus Nephritis with 12-Month Follow-Up.

Cerrillos-Gutierrez J, Medina-Perez M, Andrade-Sierra J, Garcia-Sanchez A, Cardona-Munoz E, Campos-Perez W Int J Mol Sci. 2024; 25(13).

PMID: 39000140 PMC: 11241645. DOI: 10.3390/ijms25137023.


Efferocytosis by macrophages in physiological and pathological conditions: regulatory pathways and molecular mechanisms.

Sheng Y, Hu W, Chen S, Zhu X Front Immunol. 2024; 15:1275203.

PMID: 38779685 PMC: 11109379. DOI: 10.3389/fimmu.2024.1275203.


Associations of C-reactive protein isoforms with systemic lupus erythematosus phenotypes and disease activity.

Karlsson J, Wettero J, Weiner M, Ronnelid J, Fernandez-Botran R, Sjowall C Arthritis Res Ther. 2022; 24(1):139.

PMID: 35690780 PMC: 9188243. DOI: 10.1186/s13075-022-02831-9.


Targeting DAMPs with nucleic acid scavengers to treat lupus.

Olson L, Hunter N, Rempel R, Sullenger B Transl Res. 2022; 245:30-40.

PMID: 35245691 PMC: 9167234. DOI: 10.1016/j.trsl.2022.02.007.


The Anti-DNA Antibodies: Their Specificities for Unique DNA Structures and Their Unresolved Clinical Impact-A System Criticism and a Hypothesis.

Rekvig O Front Immunol. 2022; 12:808008.

PMID: 35087528 PMC: 8786728. DOI: 10.3389/fimmu.2021.808008.